Personalizing pancreatic cancer medicine: what are the challenges?
Författare
Summary, in English
The P4 paradigm for future medicine promises changes in cancer management with improved Prediction of treatment response, Prevention of disease, Personalization of therapy, and Participation by patients. Significant challenges remain for the implementation of the P4 principles for pancreatic cancer, but many strides have been made in the past several years that should facilitate a future in which the disease can be detected at earlier stages and treatments can be customized to target features of a particular patient's disease. This article summarizes the basic molecular biology of pancreatic tumors and the current state of pancreatic cancer treatment, as well as targeted treatments in the pipeline that might enable future personalized pancreatic cancer treatment and prediction of response to treatment. It also discusses possible directions for screening patients at high risk of developing the disease, detecting tumors at earlier stages, and increasing patient involvement in designing treatment.
Avdelning/ar
- Kirurgi, Lund
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
Publiceringsår
2013
Språk
Engelska
Sidor
45-59
Publikation/Tidskrift/Serie
Personalized Medicine
Volym
10
Issue
1
Dokumenttyp
Artikel i tidskrift
Förlag
Future Science
Ämne
- Surgery
Nyckelord
- biomarkers
- P4
- pancreatic cancer
- personalized medicine
Status
Published
ISBN/ISSN/Övrigt
- ISSN: 1744-828X